ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2211

Is It Useful to Repeat an MRI of the Sacroiliac Joints in the Diagnostic Work-up for Spondyloarthritis?

Rosaline van den Berg1, Manouk de Hooge1, Victoria Navarro-Compán1, Floris van Gaalen1, Monique Reijnierse2, Tom Huizinga1 and Désirée van der Heijde1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Diagnostic imaging, Magnetic resonance imaging (MRI), radiography and spondylarthropathy

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: In the diagnostic work-up of spondyloarthritis (SpA), imaging of the sacroiliac joints by MRI (MRI-SIJ) is an important step. One study showed that in HLA-B27+ patients and male patients it might be useful to repeat an MRI-SIJ after one or two years1. It is not known if repeating an MRI-SIJ after a shorter period than 1 year is useful. Therefore, we investigated whether it is useful to repeat an MRI-SIJ after 3 months in the diagnostic process for SpA.

Methods: Patients with chronic back pain (n=157) (≥3 months, but ≤2 years, onset <45 years) included in the SPondyloArthritis Caught Early (SPACE)-cohort in the Leiden University Medical Center (LUMC) underwent an MRI-SIJ during baseline visit. All patients with SpA and possible SpA are included for follow-up (n=90) and received a second MRI-SIJ during a follow-up visit after 3 months. All MRI-SIJs of both time points were scored by 3 independent readers ‘positive' or ‘negative' according to the ASAS definition2, blinded for the time-sequence. If 2/3 reads were positive, the MRI-SIJ was marked as positive.

Univariate and multivariate regression analyses were performed to investigate which variables (IBP, elevated CRP, MRI-SIJ status at baseline, gender, HLA-B27 status and age at onset) could predict a positive MRI-SIJ at 3 months.

Results: Only patients with complete MRI-SIJ data are included in this analysis (n=90). In the univariate analysis, MRI-SIJ positivity at baseline was the strongest predictor of a positive MRI-SIJ over time (OR 51.0, 95% CI 12.2-212.8, p<0.001). Regardless MRI-SIJ status, gender and HLA-B27-status (OR 7.7, 95% CI 2.6-23.1, p<0.001 and OR 2.6, 95% CI 0.9-7.0, p=0.07, respectively) are strong predictors of a positive MRI-SIJ over time. The latter 2 variables were used in a multivariate model. Groups were made based on this model (table). In the majority of the patients (90%), MRI-SIJ status, either positive (n=15) or negative (n=66), did not change over time. Of the patients with a negative MRI-SIJ at baseline (n=71), 5 (7%) developed a positive MRI-SIJ after 3 months, and in 4/19 (21.1%) lesions on MRI-SIJ disappeared over time. Two out of 5 patients in whom MRI-SIJ was positive for the first time at follow-up fulfilled the ASAS axial SpA criteria only at follow-up.

Conclusion: We confirmed that a positive MRI-SIJ at baseline is a very strong predictor for a positive MRI-SIJ after 3 months. In patients with a negative MRI-SIJ at baseline, male gender and HLA-B27+ are predictive for a later positive MRI-SIJ.

In this group of patients with short symptom duration, variation in MRI-SIJ positivity occurred in 10% of the patients over a very short period of only 3 months. A positive change of MRI-SIJ has led to a different classification in 2 patients (2.2%). More data are needed to decide if it is necessary to repeat MRI-SIJ, and if so, with what time interval.

References:

1Van Onna M et al. ARD 2011

2Rudwaleit M et al. ARD 2009

 

 

Only baseline MRI-SIJ pos, n (%)

Only 3-months MRI-SIJ pos, n (%)

Both baseline and 3-months MRI-SIJ pos, n (%)

HLA-B27- female, n=38

1 (2.6)

1 (2.6)

2 (5.3)

HLA-B27+ female, n=21

0 (0.0)

1 (4.8)

2 (9.5)

HLA-B27- male, n=14

2 (14.3)

1 (7.1)

4 (28.6)

HLA-B27+ male, n=17

1 (5.9)

2 (11.8)

7 (41.2)

 


Disclosure:

R. van den Berg,
None;

M. de Hooge,
None;

V. Navarro-Compán,
None;

F. van Gaalen,
None;

M. Reijnierse,
None;

T. Huizinga,
None;

D. van der Heijde,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-it-useful-to-repeat-an-mri-of-the-sacroiliac-joints-in-the-diagnostic-work-up-for-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology